| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
Gene Regulation Section, Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, Maryland
Requests for reprints: Aaron P. Jansen, National Cancer Institute-Frederick, Building 567, Room 187, Frederick, MD 21702. Phone: 301-846-6850; Fax: 301-846-6907; E-mail: ajansen{at}ncifcrf.gov.
Programmed cell death 4 (Pdcd4) is a novel repressor of in vitro transformation. Pdcd4 directly inhibits the helicase activity of eukaryotic translation initiation factor 4A, a component of the translation initiation complex. To ascertain whether Pdcd4 suppresses tumor development in vivo, we have generated transgenic mice that overexpress Pdcd4 in the epidermis (K14-Pdcd4). K14-regulated Pdcd4 expression caused a neonatal short-hair phenotype due to early catagen entry compared with matched wild-type siblings. In response to the 7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) mouse skin carcinogenesis protocol, K14-Pdcd4 mice showed significant reductions in papilloma formation, carcinoma incidence, and papilloma-to-carcinoma conversion frequency compared with wild-type mice. The translational efficiency of an mRNA engineered to form a structured 5' untranslated region (UTR) was attenuated in primary keratinocytes when Pdcd4 was overexpressed. Pdcd4 inhibited by 46% TPA-induced activator protein-1 (AP-1)dependent transcription, an event required for tumorigenesis. CDK4 and ornithine decarboxylase (ODC) are candidates for Pdcd4-regulated translation as their mRNAs contain 5'structured UTRs. In K14-Pdcd4 primary keratinocytes expressing activated Ha-Ras to mimic DMBA-initiated epidermis, ODC and CDK4 protein levels were decreased by 40% and 46%, respectively. Expression of a protein encoded by 5' unstructured mRNA showed no change. These results extend to an in vivo model the observations that Pdcd4 inhibits both translation initiation and AP-1 activation while decreasing benign tumor development and malignant progression. The K14-Pdcd4 mice seem to validate translation initiation as a novel target for cancer prevention.
This article has been cited by other articles:
![]() |
N. Carayol, E. Katsoulidis, A. Sassano, J. K. Altman, B. J. Druker, and L. C. Platanias Suppression of Programmed Cell Death 4 (PDCD4) Protein Expression by BCR-ABL-regulated Engagement of the mTOR/p70 S6 Kinase Pathway J. Biol. Chem., March 28, 2008; 283(13): 8601 - 8610. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schmid, A. P. Jansen, A. R. Baker, G. Hegamyer, J. P. Hagan, and N. H. Colburn Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion Cancer Res., March 1, 2008; 68(5): 1254 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Frankel, N. R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A. H. Lund Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells J. Biol. Chem., January 11, 2008; 283(2): 1026 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. LaRonde-LeBlanc, A. N. Santhanam, A. R. Baker, A. Wlodawer, and N. H. Colburn Structural Basis for Inhibition of Translation by the Tumor Suppressor Pdcd4 Mol. Cell. Biol., January 1, 2007; 27(1): 147 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ozpolat, U. Akar, M. Steiner, I. Zorrilla-Calancha, M. Tirado-Gomez, N. Colburn, M. Danilenko, S. Kornblau, and G. Lopez Berestein Programmed Cell Death-4 Tumor Suppressor Protein Contributes to Retinoic Acid-Induced Terminal Granulocytic Differentiation of Human Myeloid Leukemia Cells Mol. Cancer Res., January 1, 2007; 5(1): 95 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hilliard, B. Hilliard, S.-J. Zheng, H. Sun, T. Miwa, W. Song, R. Goke, and Y. H. Chen Translational Regulation of Autoimmune Inflammation and Lymphoma Genesis by Programmed Cell Death 4 J. Immunol., December 1, 2006; 177(11): 8095 - 8102. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. V. Dorrello, A. Peschiaroli, D. Guardavaccaro, N. H. Colburn, N. E. Sherman, and M. Pagano S6K1- and {beta}TRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth. Science, October 20, 2006; 314(5798): 467 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jin, T. H. Kim, S.-K. Hwang, S.-H. Chang, H. W. Kim, H. K. Anderson, H.-W. Lee, K.-H. Lee, N. H. Colburn, H.-S. Yang, et al. Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol. Cancer Ther., April 1, 2006; 5(4): 1041 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Yang, C. P. Matthews, T. Clair, Q. Wang, A. R. Baker, C.-C. H. Li, T.-H. Tan, and N. H. Colburn Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion Mol. Cell. Biol., February 15, 2006; 26(4): 1297 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Palamarchuk, A. Efanov, V. Maximov, R. I. Aqeilan, C. M. Croce, and Y. Pekarsky Akt Phosphorylates and Regulates Pdcd4 Tumor Suppressor Protein Cancer Res., December 15, 2005; 65(24): 11282 - 11286. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |